临床肝胆病杂志2025，Vol.41Issue(6)：1043-1052,10.DOI:10.12449/JCH250607
《2025年亚太肝病学会临床实践指南:代谢相关脂肪性肝病的诊断和管理》摘译与解读
Excerpt and interpretation of the Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease in 2025
摘要
Abstract
Since the Asia-Pacific Association for the Study of the Liver(APASL)issued the clinical practice guidelines for metabolic associated fatty liver disease(MAFLD)in 2020,the research on MAFLD has been further deepened.Therefore,APASL has made comprehensive updates and revisions based on the previous guidelines,and the latest version of the clinical practice guidelines for diagnosis and management of MAFLD,which was released in February 2025,has updated the epidemiology,screening,assessment,and treatment of MAFLD,aiming to promote the clinical practice,knowledge popularization,and scientific research of MAFLD.This article makes an excerpt and an interpretation of the updated key points of the guidelines.关键词
代谢相关脂肪性肝病/诊断/治疗学/诊疗准则Key words
Metabolic Dysfunction-Associated Fatty Liver Disease/Diagnosis/Therapeutics/Practice Guideline引用本文复制引用
雷偲艺,连莉优,郑明华..《2025年亚太肝病学会临床实践指南:代谢相关脂肪性肝病的诊断和管理》摘译与解读[J].临床肝胆病杂志,2025,41(6):1043-1052,10.基金项目
国家重点研发项目(2023YFA1800801) （2023YFA1800801）
国家科技重大专项(2023ZD0508700) （2023ZD0508700）
国家自然科学基金(82070588,82370577) National Key R&D Program of China(2023YFA1800801) （82070588,82370577）
National Science and Technology Major Project(2023ZD0508700) （2023ZD0508700）
National Natural Science Foundation of China(82070588,82370577) （82070588,82370577）
